Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Benzinga
Chartmill
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
Talk Markets
Press Releases
24-7 Press Release
AB Newswire
ACCESSWIRE
ACN Newswire
Authority Press Wire
Binary News Network
Brandpoint
Business Wire
CannabisNewsWire
CryptoCurrencyWire
eTrendy Stock
FinancialNewsMedia
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
News Direct
Newsfile
NewsUSA
Newswire.com
Newsworthy.ai
Press Advantage
Press Connect
Press Release Distribution Service
PressReach
PRLeap
PRLog
Prodigy
ReleaseWire
Small Business Trendsetters
StatePoint
Syndication Cloud
TheNewswire
Zexprwire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase Ib Clinical Trial Evaluating PEP-010 in Ovarian and Pancreatic Cancers
Today 5:00 EDT
From
PEP-Therapy
Via
GlobeNewswire
REVIVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reviva Pharmaceuticals Holdings, Inc. on Behalf of Reviva Stockholders and Encourages Investors to Contact the Firm
Today 5:00 EDT
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
RVPH
OKX Continues to Lead in Trust and Transparency with 18th Consecutive Proof of Reserves, Amounting to USD22.3 Billion
Today 4:00 EDT
From
OKX
Via
GlobeNewswire
Less than half of veterinary professionals feel their profession is appreciated
Today 3:00 EDT
From
Boehringer Ingelheim
Via
GlobeNewswire
Crossject reports audited financial results for 2023
Today 1:32 EDT
From
CROSSJECT
Via
GlobeNewswire
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
Today 1:30 EDT
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
Today 1:30 EDT
From
ONWARD Medical NV
Via
GlobeNewswire
STMicroelectronics Reports 2024 First Quarter Financial Results
Today 1:00 EDT
From
STMicroelectronics N.V.
Via
GlobeNewswire
Tickers
STM
Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
Today 1:00 EDT
From
Santhera Pharmaceuticals Holding AG
Via
GlobeNewswire
Equinor to commence second tranche of the 2024 share buy-back programme
Today 0:47 EDT
From
Equinor ASA
Via
GlobeNewswire
Equinor ASA: Key information relating to cash dividend for first quarter 2024
Today 0:46 EDT
From
Equinor ASA
Via
GlobeNewswire
Equinor first quarter 2024 results
Today 0:45 EDT
From
Equinor ASA
Via
GlobeNewswire
Few small SUVs excel in new IIHS front crash prevention test
Today 0:01 EDT
From
Insurance Institute for Highway Safety
Via
GlobeNewswire
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
April 24, 2024
From
Junshi Biosciences
Via
GlobeNewswire
AUTODESK ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Autodesk, Inc. and Encourages Investors to Contact the Firm
April 24, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
ADSK
Marex Group plc Announces Pricing of Initial Public Offering
April 24, 2024
From
Marex Group plc
Via
GlobeNewswire
UnitedAg CONNECT Conference 2024: A Resounding Success
April 24, 2024
From
UnitedAg
Via
GlobeNewswire
TransAlta Declares Dividends
April 24, 2024
From
TransAlta Corporation
Via
GlobeNewswire
Tickers
TAC
TSX:TA
Ero Copper Announces Voting Results of Annual General Meeting of Shareholders
April 24, 2024
From
Ero Copper Corp.
Via
GlobeNewswire
Tickers
ERO
TSX:ERO
LANTRONIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Lantronix, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
April 24, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
LTRX
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Checkpoint, Sonder, and Perion and Encourages Investors to Contact the Firm
April 24, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
CKPT
PERI
SOND
Net Income of R$ 55.3 mm in 1Q24, a 90.1% Increase YOY and Leases EBITDA Margin of 72.1%
April 24, 2024
From
LOG COMMERCIAL PROPERTIES
Via
GlobeNewswire
Air Methods Ascend Partners with SimX to Soar to New Heights in Critical Care Education
April 24, 2024
From
Air Methods Ascend
Via
GlobeNewswire
Rogers Communications Announces Voting Results from Annual and Special Meeting of Shareholders
April 24, 2024
From
Rogers Communications, Inc.
Via
GlobeNewswire
Tickers
RCI
TSX:RCI-A
TSX:RCI-B
ROSEN, THE FIRST FILING FIRM, Encourages Luna Innovations Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LUNA
April 24, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Tickers
LUNA
The Lundquist Institute Receives $2.6 Million Grant from U.S. Army Medical Research Acquisition Activity to Develop Wearable Biosensors
April 24, 2024
From
The Lundquist Institute for Biomedical Innovation
Via
GlobeNewswire
ROSEN, A RANKED AND LEADING FIRM, Encourages Innoviz Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INVZ, INVZW
April 24, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Tickers
INVZ
INVZW
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
April 24, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Tickers
GDRX
Futu Holdings Limited Announces Filing of Its Annual Report on Form 20-F for Fiscal Year 2023
April 24, 2024
From
Futu Holdings Limited
Via
GlobeNewswire
Tickers
FUTU
ROSEN, LEADING INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
April 24, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Tickers
DOCS
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.